Journal
EMERGING INFECTIOUS DISEASES
Volume 13, Issue 10, Pages 1562-1564Publisher
CENTER DISEASE CONTROL
DOI: 10.3201/eid1310.070576
Keywords
-
Categories
Ask authors/readers for more resources
Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and significant reduction of immunoglobulin G-positive percentage and titers occurred in the third year. Thus, SARS patients might be susceptible to reinfection >= 3 years after initial exposure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available